|
2811
|
25CN-NBOH hydrochloride
|
Selective brain penetrant 5-HT2A receptor agonist |
€145.00
|
|
1575
|
5-HT6 antagonist 29
|
Selective brain penetrant 5-HT6 receptor antagonist |
€90.00
|
|
2944
|
A 381393
|
Potent, brain-penetrant, selective antagonist of the dopamine D4 receptor |
€125.00
|
|
1744
|
A 77-01
|
TGF-βR 1 inhibitor; ALK 5 inhibitor |
€80.00
|
|
1421
|
A 83-01
|
TGF-βR 1 inhibitor; ALK 5 inhibitor |
€70.00
|
|
2155
|
A 841720
|
Non-competitive mGluR1 antagonist |
€85.00
|
|
1990
|
A 943931
|
H4 antagonist |
€75.00
|
|
1179
|
A1B1 hydrochloride
|
CCR1 antagonist |
€125.00
|
|
1419
|
AB 1010
|
PDGFR, c-KIT and FGFR3 tyrosine kinase inhibitor |
€70.00
|
|
3040
|
Abivertinib
|
Potent oral, irreversible, third-generation EGFR TKI with selectivity for mutant EGFRs |
€95.00
|
|
1510
|
ABT 239 tartrate
|
H3 antagonist/inverse agonist |
€135.00
|
|
1250
|
ABT 724 trihydrochloride
|
D4 agonist |
€85.00
|
|
1638
|
ABT 869
|
PDGFR, c-KIT and VEGFR tyrosine kinase inhibitor |
€85.00
|
|
1696
|
AC 220 dihydrochloride
|
FLT3 inhibitor |
€90.00
|
|
2898
|
AC 264613
|
Potent, selective, and metabolically stable PAR2 agonist |
€95.00
|